MedTrace Logo

Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing

NCT02786498 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2022-03-31

Study results available
· View outcomes & findings →

Summary

The objective is to determine the effect of vitamin D3 supplementation on fracture healing at 3 months.

Conditions

  • Fracture

Interventions

DRUG

Vitamin D3

OTHER

Placebo

Sponsors & Collaborators

Principal Investigators

  • Gerard Slobogean, MD · University of Maryland

  • Sheila Sprague, PhD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-21
Primary Completion
2019-08-31
Completion
2021-12-01
FDA Drug
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02786498 on ClinicalTrials.gov